Supplement

You have full text access to this OnlineOpen article

Environmental pollutants and breast cancer

Epidemiologic studies

  1. Julia Green Brody PhD1,†,*,
  2. Kirsten B. Moysich PhD2,
  3. Olivier Humblet MS1,
  4. Kathleen R. Attfield BS1,
  5. Gregory P. Beehler MA2,
  6. Ruthann A. Rudel MS1

Article first published online: 14 MAY 2007

DOI: 10.1002/cncr.22655

Issue

Cancer

Cancer

Supplement: Environmental Factors in Breast Cancer

Volume 109, Issue Supplement 12, pages 2667–2711, 15 June 2007

Additional Information

How to Cite

Brody, J. G., Moysich, K. B., Humblet, O., Attfield, K. R., Beehler, G. P. and Rudel, R. A. (2007), Environmental pollutants and breast cancer. Cancer, 109: 2667–2711. doi: 10.1002/cncr.22655

Author Information

  1. 1

    Silent Spring Institute, Newton, Massachusetts

  2. 2

    Department of Epidemiology, Roswell Park Cancer Institute, Buffalo, New York

  1. †

    Fax: (617) 332-4284

*Silent Spring Institute, 29 Crafts Street, Newton, MA 02458

Publication History

  1. Issue published online: 4 JUN 2007
  2. Article first published online: 14 MAY 2007
  3. Manuscript Accepted: 3 JAN 2007
  4. Manuscript Revised: 10 NOV 2006
  5. Manuscript Received: 18 JUL 2006

Funded by

  • Susan G. Komen for the Cure as part of the Environmental Factors and Breast Cancer Science Review project

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (342K)

REFERENCES

  • 1
    Rudel RA, Attfield KR, Schifano JN, Brody JG. Chemicals causing mammary gland tumors in animals signal new directions for epidemiology, chemicals testing, and risk assessment for breast cancer prevention. Cancer. 2007; 109: 000–000.
    Direct Link:
  • 2
    Institute for Environment and Health. Chemicals purported to be endocrine disrupters: a compilation of published lists. Available at http://www.silsoe.cranfield.ac.uk/ieh/pdf/w20.pdf Accessed on November 10, 2006.
  • 3
    Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO. The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants. Environ Health Perspect. 1995; 103: 113–122.
  • 4
    Bernstein L. Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia. 2002; 7: 3–15.
  • 5
    Markey CM, Wadia PR, Rubin BS, Sonnenschein C, Soto AM. Long-term effects of fetal exposure to low doses of the xenoestrogen bisphenol-A in the female mouse genital tract. Biol Reprod. 2005; 72: 1344–1351.
  • 6
    Birnbaum LS, Fenton SE. Cancer and developmental exposure to endocrine disruptors. Environ Health Perspect. 2003; 111: 389–394.
  • 7
    Rayner JL, Enoch RR, Fenton SE. Adverse effects of prenatal exposure to atrazine during a critical period of mammary gland growth. Toxicol Sci. 2005; 87: 255–266.
  • 8
    National Center for Health Statistics. Mortality Data, Underlying Cause-of-Death Public-Use Data Files. Tenth Revision. 39 Selected Causes of Death for Mortality Files From 1999 to 2003. 2006. Available at http://www.cdc.gov/nchs/products/elec_prods/subject/mortucd.htm Accessed on November 6, 2006.
  • 9
    National Center for Environmental Health, Third National Report on Human Exposure Environmental Chemicals. Atlanta, GA: Centers for Disease Control; 2005.
  • 10
    Rudel RA, Camann DE, Spengler JD, Korn LR, Brody JG. Phthalates, alkylphenols, pesticides, polybrominated diphenyl ethers, and other endocrine disrupting compounds in indoor air and dust. Environ Sci Technol. 2003; 37: 4543–4553.
  • 11
    Brody JG, Rudel RA. Environmental pollutants and breast cancer. Environ Health Perspect. 2003; 111: 1007–1019.
  • 12
    Wolff MS, Britton JA, Russo JC. TCDD and puberty in girls. Environ Health Perspect. 2005; 113: A17; author reply A18.
  • 13
    Snedeker SM. Pesticides and breast cancer risk: a review of DDT, DDE, and dieldrin. Environ Health Perspect. 2001; 109( Suppl 1): 35–47.
  • 14
    Moysich KB, Menezes RJ, Baker JA, Falkner KL. Environmental exposure to polychlorinated biphenyls and breast cancer risk. Rev Environ Health. 2002; 17: 263–277.
  • 15
    Negri E, Bosetti C, Fattore E, La Vecchia C. Environmental exposure to polychlorinated biphenyls (PCBs) and breast cancer: a systematic review of the epidemiological evidence. Eur J Cancer Prev. 2003; 12: 509–516.
  • 16
    Bajdik CD, Fang R, Band PR, Le N, Gallagher RP. Do work-related breast cancer risks in pre-menopausal women depend on family history? Chronic Dis Can. 2004; 25: 147–151.
  • 17
    Reynolds P, Cone J, Layefsky M, Goldberg DE, Hurley S. Cancer incidence in California flight attendants (United States). Cancer Causes Control. 2002; 13: 317–324.
  • 18
    Doody MM, Mandel JS, Boice JDJr. Employment practices and breast cancer among radiologic technologists. J Occup Environ Med. 1995; 37: 321–327.
  • 19
    Zahm SH, Blair A. Occupational cancer among women: where have we been and where are we going? Am J Ind Med. 2003; 44: 565–575.
    Direct Link:
  • 20
    Rix BA, Lynge E. Cancer incidence in Danish health care workers. Scand J Soc Med. 1996; 24: 114–120.
  • 21
    Aschengrau A, Seage G. Essentials of Epidemiology in Public Health. Sudbury, MA: Jones & Bartlett; 2003.
  • 22
    Aschengrau A, Rogers S, Ozonoff D. Perchloroethylene-contaminated drinking water and the risk of breast cancer: additional results from Cape Cod, Massachusetts, USA. Environ Health Perspect. 2003; 111: 167–173.
  • 23
    Coyle YM, Hynan LS, Euhus DM, Minhajuddin AT. An ecological study of the association of environmental chemicals on breast cancer incidence in Texas. Breast Cancer Res Treat. 2005; 92: 107–114.
  • 24
    Wolff MS, Britton JA, Teitelbaum SL, et al. Improving organochlorine biomarker models for cancer research. Cancer Epidemiol Biomarkers Prev. 2005; 14: 2224–2236.
  • 25
    Wolff MS, Deych E, Ojo F, Berkowitz GS. Predictors of organochlorines in New York City pregnant women, 1998–2001. Environ Res. 2005; 97: 170–177.
  • 26
    Wolff MS, Zeleniuch-Jacquotte A, Dubin N, Toniolo P. Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev. 2000; 9: 271–277.
  • 27
    Wolff MS, Berkowitz GS, Brower S, et al. Organochlorine exposures and breast cancer risk in New York City women. Environ Res. 2000; 84: 2151–161.
  • 28
    Hoyer AP, Jorgensen T, Brock JW, Grandjean P. Organochlorine exposure and breast cancer survival. J Clin Epidemiol. 2000; 53: 323–330.
  • 29
    Laden F, Collman G, Iwamoto K, et al. 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five U.S. studies. J Natl Cancer Inst (1988). 2001; 93: 768–776.
  • 30
    Lopez-Carrillo L, Lopez-Cervantes M, Torres-Sanchez L, Blair A, Cebrian ME, Garcia RM. Serum levels of beta-hexachlorocyclohexane, hexachlorobenzene and polychlorinated biphenyls and breast cancer in Mexican women. Eur J Cancer Prev. 2002; 11: 129–135.
  • 31
    Pavuk M, Cerhan JR, Lynch CF, Kocan A, Petrik J, Chovancova J. Case-control study of PCBs, other organochlorines and breast cancer in Eastern Slovakia. J Expo Anal Environ Epidemiol. 2003; 13: 267–275.
  • 32
    Millikan R, DeVoto E, Duell EJ, et al. Dichlorodiphenyldichloroethene, polychlorinated biphenyls, and breast cancer among African-American and white women in North Carolina. Cancer Epidemiol Biomarkers Prev. 2000; 9: 1233–1240.
  • 33
    Zheng T, Holford TR, Mayne ST, et al. Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2'-bis(p-chlorophenyl)ethylene. Cancer Epidemiol Biomarkers Prev. 2000; 9: 167–174.
  • 34
    Raaschou-Nielsen O, Pavuk M, Leblanc A, et al. Adipose organochlorine concentrations and risk of breast cancer among postmenopausal Danish women. Cancer Epidemiol Biomarkers Prev. 2005; 14: 67–74.
  • 35
    Ward EM, Schulte P, Grajewski B, et al. Serum organochlorine levels and breast cancer: a nested case-control study of Norwegian women. Cancer Epidemiol Biomarkers Prev. 2000; 9: 1357–1367.
  • 36
    Demers A, Ayotte P, Brisson J, Dodin S, Robert J, Dewailly E. Plasma concentrations of polychlorinated biphenyls and the risk of breast cancer: a congener-specific analysis. Am J Epidemiol. 2002; 155: 629–635.
  • 37
    Holford TR, Zheng T, Mayne ST, Zahm SH, Tessari JD, Boyle P. Joint effects of nine polychlorinated biphenyl (PCB) congeners on breast cancer risk. Int J Epidemiol. 2000; 29: 975–982.
  • 38
    Zhang Y, Wise JP, Holford TR, et al. Serum polychlorinated biphenyls, cytochrome P-450 1A1 polymorphisms, and risk of breast cancer in Connecticut women. Am J Epidemiol. 2004; 160: 1177–1183.
  • 39
    Moysich KB, Shields PG, Freudenheim JL, et al. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1999; 8: 41–44.
  • 40
    Laden F, Ishibe N, Hankinson SE, et al. Polychlorinated biphenyls, cytochrome P450 1A1, and breast cancer risk in the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev. 2002; 11: 1560–1565.
  • 41
    Alexandrov K, Cascorbi I, Rojas M, Bouvier G, Kriek E, Bartsch H. CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation. Carcinogenesis. 2002; 23: 1969–1977.
  • 42
    Li Y, Millikan RC, Bell DA, et al. Polychlorinated biphenyls, cytochrome P450 1A1 (CYP1A1) polymorphisms, and breast cancer risk among African American women and white women in North Carolina: a population-based case-control study. Breast Cancer Res. 2005; 7: R12–18.
  • 43
    McCready D, Aronson KJ, Chu W, Fan W, Vesprini D, Narod SA. Breast tissue organochlorine levels and metabolic genotypes in relation to breast cancer risk Canada. Cancer Causes Control. 2004; 15: 399–418.
  • 44
    Hoyer AP, Gerdes AM, Jorgensen T, Rank F, Hartvig HB. Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case-controls study. Breast Cancer Res Treat. 2002; 71: 59–65.
  • 45
    Helzlsouer KJ, Alberg AJ, Huang HY, et al. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers Prev. 1999; 8: 525–532.
  • 46
    Muscat JE, Britton JA, Djordjevic MV, et al. Adipose concentrations of organochlorine compounds and breast cancer recurrence in Long Island, New York. Cancer Epidemiol Biomarkers Prev. 2003; 12: 1474–1478.
  • 47
    Hoyer AP, Jorgensen T, Rank F, Grandjean P. Organochlorine exposures influence on breast cancer risk and survival according to estrogen receptor status: a Danish cohort-nested case-control study. BMC Cancer. 2001; 1: 8.
  • 48
    Steenland K, Bertazzi P, Baccarelli A, Kogevinas M. Dioxin revisited: developments since the 1997 IARC classification of dioxin as a human carcinogen. Environ Health Perspect. 2004; 112: 1265–1268.
  • 49
    Kogevinas M. Human health effects of dioxins: cancer, reproductive and endocrine system effects. Hum Reprod Update. 2001; 7: 331–339.
  • 50
    Schecter A, Startin J, Wright C, et al. Congener-specific levels of dioxins and dibenzofurans in U.S. food and estimated daily dioxin toxic equivalent intake. Environ Health Perspect. 1994; 102: 962–966.
  • 51
    Warner M, Eskenazi B, Mocarelli P, et al. Serum dioxin concentrations and breast cancer risk in the Seveso Women's Health Study. Environ Health Perspect. 2002; 110: 625–628.
  • 52
    Bertazzi A, Pesatori AC, Consonni D, Tironi A, Landi MT, Zocchetti C. Cancer incidence in a population accidentally exposed to 2,3,7,8-tetrachlorodibenzo-para-dioxin. Epidemiology. 1993; 4: 398–406.
  • 53
    Bertazzi PA, Zocchetti C, Guercilena S, et al. Dioxin exposure and cancer risk: a 15-year mortality study after the “Seveso accident.” Epidemiology. 1997; 8: 646–652.
  • 54
    Revich B, Aksel E, Ushakova T, et al. Dioxin exposure and public health in Chapaevsk, Russia. Chemosphere. 2001; 43: 951–966.
  • 55
    Manz A, Berger J, Dwyer JH, Flesch-Janys D, Nagel S, Waltsgott H. Cancer mortality among workers in chemical plant contaminated with dioxin. Lancet. 1991; 338: 959–964.
  • 56
    Flesch-Janys D, Becher J, Berger J, et al. Epidemiological investigation of breast cancer incidence in a cohort of female workers with high exposure to PCDD/F and HCH. Organohalogen Compounds. 1999; 44: 379–382.
  • 57
    Saracci R, Kogevinas M, Bertazzi PA, et al. Cancer mortality in workers exposed to chlorophenoxy herbicides and chlorophenols. Lancet. 1991; 338: 1027–1032.
  • 58
    Kogevinas M, Saracci R, Winkelmann R, et al. Cancer incidence and mortality in women occupationally exposed to chlorophenoxy herbicides, chlorophenols, and dioxins. Cancer Causes Control. 1993; 4: 547–553.
  • 59
    Kogevinas M, Becher H, Benn T, et al. Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol. 1997; 145: 1061–1075.
  • 60
    Hardell L, Lindstrom G, Liljegren G, Dahl P, Magnuson A. Increased concentrations of octachlorodibenzo-p-dioxin in cases with breast cancer—results from a case-control study. Eur J Cancer Prev. 1996; 5: 351–357.
  • 61
    Reynolds P, Hurley SE, Petreas M, et al. Adipose levels of dioxins and risk of breast cancer. Cancer Causes Control. 2005; 16: 525–535.
  • 62
    Charlier C, Albert A, Herman P, et al. Breast cancer and serum organochlorine residues. Occup Environ Med. 2003; 60: 348–351.
  • 63
    Charlier C, Foidart JM, Pitance F, et al. Environmental dichlorodiphenyltrichloroethane or hexachlorobenzene exposure and breast cancer: is there a risk? Clin Chem Lab Med. 2004; 42: 222–227.
  • 64
    Romieu I, Hernandez-Avila M, Lazcano-Ponce E, Weber JP, Dewailly E. Breast cancer, lactation history, and serum organochlorines. Am J Epidemiol. 2000; 152: 363–370.
  • 65
    Gammon MD, Wolff MS, Neugut AI, et al. Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood. Cancer Epidemiol Biomarkers Prev. 2002; 11: 686–697.
  • 66
    Lopez-Cervantes M, Torres-Sanchez L, Tobias A, Lopez-Carrillo L. Dichlorodiphenyldichloroethane burden and breast cancer risk: a meta-analysis of the epidemiologic evidence. Environ Health Perspect. 2004; 112: 207–214.
  • 67
    Demers A, Ayotte P, Brisson J, Dodin S, Robert J, Dewailly E. Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentrations. Cancer Epidemiol Biomarkers Prev. 2000; 9: 161–166.
  • 68
    Brody JG, Vorhees DJ, Melly SJ, Swedis SR, Drivas PJ, Rudel RA. Using GIS and historical records to reconstruct residential exposure to large-scale pesticide application. J Expo Anal Environ Epidemiol. 2002; 12: 64–80.
  • 69
    Brody JG, Aschengrau A, McKelvey W, Rudel RA, Swartz CH, Kennedy T. Breast cancer risk and historical exposure to pesticides from wide-area applications assessed with GIS. Environ Health Perspect. 2004; 112: 889–897.
  • 70
    Aschengrau A, Ozonoff D, Coogan P, Vezina R, Heeren T, Zhang Y. Cancer risk and residential proximity to cranberry cultivation in Massachusetts. Am J Public Health. 1996; 86: 1289–1296.
  • 71
    O'Leary ES, Vena JE, Freudenheim JL, Brasure J. Pesticide exposure and risk of breast cancer: a nested case-control study of residentially stable women living on Long Island. Environ Res. 2004; 94: 134–144.
  • 72
    Reynolds P, Hurley SE, Goldberg DE, et al. Residential proximity to agricultural pesticide use and incidence of breast cancer in the California Teachers Study cohort. Environ Res. 2004; 96: 206–218.
  • 73
    Mills PK, Yang R. Breast cancer risk in Hispanic agricultural workers in California. Int J Occup Environ Health. 2005; 11: 123–131.
  • 74
    Engel LS, Hill DA, Hoppin JA, et al. Pesticide use and breast cancer risk among farmers' wives in the agricultural health study. Am J Epidemiol. 2005; 161: 121–135.
  • 75
    Duell EJ, Millikan RC, Savitz DA, et al. A population-based case-control study of farming and breast cancer in North Carolina. Epidemiology. 2000; 11: 523–531.
  • 76
    Dolapsakis G, Vlachonikolis IG, Varveris C, Tsatsakis AM. Mammographic findings and occupational exposure to pesticides currently in use on Crete. Eur J Cancer. 2001; 37: 1531–1536.
  • 77
    Castano-Vinyals G, D'Errico A, Malats N, Kogevinas M. Biomarkers of exposure to polycyclic aromatic hydrocarbons from environmental air pollution. Occup Environ Med. 2004; 61: e12.
  • 78
    Terry MB, Gammon MD, Zhang FF, et al. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2004; 13: 2053–2058.
  • 79
    Gammon MD, Santella RM, Neugut AI, et al. Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prev. 2002; 11: 677–685.
  • 80
    Shantakumar S, Gammon MD, Eng SM, et al. Residential environmental exposures and other characteristics associated with detectable PAH-DNA adducts in peripheral mononuclear cells in a population-based sample of adult females. J Expo Anal Environ Epidemiol. 2005; 15: 482–490.
  • 81
    Shen J, Gammon MD, Terry MB, et al. Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005; 14: 336–342.
  • 82
    Tang D, Cho S, Rundle A, et al. Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case-control study of breast cancer. Breast Cancer Res Treat. 2002; 75: 159–166.
  • 83
    Tang D, Rundle A, Mooney L, et al. Sulfotransferase 1A1 (SULT1A1) polymorphism, PAH-DNA adduct levels in breast tissue and breast cancer risk in a case-control study. Breast Cancer Res Treat. 2003; 78: 217–222.
  • 84
    Rundle A, Tang D, Hibshoosh H, et al. Molecular epidemiologic studies of polycyclic aromatic hydrocarbon-DNA adducts and breast cancer. Environ Mol Mutagen. 2002; 39: 201–207.
    Direct Link:
  • 85
    Rundle A, Tang D, Zhou J, Cho S, Perera F. The association between glutathione S-transferase M1 genotype and polycyclic aromatic hydrocarbon-DNA adducts in breast tissue. Cancer Epidemiol Biomarkers Prev. 2000; 9: 1079–1085.
  • 86
    Bonner MR, Han D, Nie J, et al. Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epidemiol Biomarkers Prev. 2005; 14: 53–60.
  • 87
    Lewis-Michl EL, Melius JM, Kallenbach LR, et al. Breast cancer risk and residence near industry or traffic in Nassau and Suffolk Counties, Long Island, New York. Arch Environ Health. 1996; 51: 255–265.
  • 88
    Petralia SA, Vena JE, Freudenheim JL, et al. Risk of premenopausal breast cancer in association with occupational exposure to polycyclic aromatic hydrocarbons and benzene. Scand J Work Environ Health. 1999; 25: 215–221.
  • 89
    Hansen J. Elevated risk for male breast cancer after occupational exposure to gasoline and vehicular combustion products. Am J Ind Med. 2000; 37: 349–352.
    Direct Link:
  • 90
    Li D, Wang M, Dhingra K, Hittelman WN. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res. 1996; 56: 287–293.
  • 91
    Rundle A, Tang D, Hibshoosh H, et al. The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Carcinogenesis. 2000; 21: 1281–1289.
  • 92
    Motykiewicz G, Malusecka E, Michalska J, et al. Immunoperoxidase detection of polycyclic aromatic hydrocarbon-DNA adducts in breast tissue sections. Cancer Detect Prev. 2001; 25: 328–335.
  • 93
    World Health Organization International Program on Chemical Safety. Environmental Health Criteria # 216 — Disinfectants and Disinfectant By-Products. Geneva: World Health Organization; 2000.
  • 94
    McDonald TA, Komulainen H. Carcinogenicity of the chlorination disinfection by-product MX. J Environ Sci Health C Environ Carcinog. Ecotoxicol Rev. 2005; 23: 163–214.
  • 95
    Morris RD, Audet AM, Angelillo IF, Chalmers TC, Mosteller F. Chlorination, chlorination by-products, and cancer: a meta-analysis. Am J Public Health. 1992; 82: 955–963.
  • 96
    Swartz CH, Rudel RA, Kachajian JR, Brody JG. Historical reconstruction of wastewater and land use impacts to groundwater used for public drinking water: exposure assessment using chemical data and GIS. J Expo Anal Environ Epidemiol. 2003; 13: 403–416.
  • 97
    Labreche FP, Goldberg MS. Exposure to organic solvents and breast cancer in women: a hypothesis. Am J Ind Med. 1997; 32: 1–14.
    Direct Link:
  • 98
    Cantor KP, Stewart PA, Brinton LA, Dosemeci M. Occupational exposures and female breast cancer mortality in the United States. J Occup Environ Med. 1995; 37: 336–348.
  • 99
    Benzene toxicity, carcinogenesis, and epidemiology. Environ Health Perspect. 1996; 104( Suppl 6): 1339–1398.
  • 100
    Hansen J. Breast cancer risk among relatively young women employed in solvent-using industries. Am J Ind Med. 1999; 36: 43–47.
    Direct Link:
  • 101
    Band PR, Le ND, Fang R, Deschamps M, Gallagher RP, Yang P. Identification of occupational cancer risks in British Columbia. A population-based case-control study of 995 incident breast cancer cases by menopausal status, controlling for confounding factors. J Occup Environ Med. 2000; 42: 284–310.
  • 102
    Lamba AB, Ward MH, Weeks JL, Dosemeci M. Cancer mortality patterns among hairdressers and barbers in 24 U.S. states, 1984 to 1995. J Occup Environ Med. 2001; 43: 250–258.
  • 103
    Pollan M, Gustavsson P. High-risk occupations for breast cancer in the Swedish female working population. Am J Public Health. 1999; 89: 875–881.
  • 104
    Gardner KM, Ou Shu X, Jin F, et al. Occupations and breast cancer risk among Chinese women in urban Shanghai. Am J Ind Med. 2002; 42: 296–308.
    Direct Link:
  • 105
    Blair A, Hartge P, Stewart PA, McAdams M, Lubin J. Mortality and cancer incidence of aircraft maintenance workers exposed to trichloroethylene and other organic solvents and chemicals: extended follow up. Occup Environ Med. 1998; 55: 161–171.
  • 106
    Rennix CP, Quinn MM, Amoroso PJ, Eisen EA, Wegman DH. Risk of breast cancer among enlisted Army women occupationally exposed to volatile organic compounds. Am J Ind Med. 2005; 48: 157–167.
    Direct Link:
  • 107
    Chang YM, Tai CF, Lin RS, et al. A proportionate cancer morbidity ratio study of workers exposed to chlorinated organic solvents in Taiwan. Ind Health. 2003; 41: 77–87.
  • 108
    Chang YM, Tai CF, Yang SC, et al. A cohort mortality study of workers exposed to chlorinated organic solvents in Taiwan. Ann Epidemiol. 2003; 13: 652–660.
  • 109
    Chang YM, Tai CF, Yang SC, et al. Cancer incidence among workers potentially exposed to chlorinated solvents in an electronics factory. J Occup Health. 2005; 47: 171–180.
  • 110
    Gunnarsdottir H, Rafnsson V. Cancer incidence among Icelandic nurses. J Occup Environ Med. 1995; 37: 307–312.
  • 111
    Norman SA, Berlin JA, Soper KA, Middendorf BF, Stolley PD. Cancer incidence in a group of workers potentially exposed to ethylene oxide. Int J Epidemiol. 1995; 24: 276–284.
  • 112
    Goldberg MS, Labreche F. Occupational risk factors for female breast cancer: a review. Occup Environ Med. 1996; 53: 145–156.
  • 113
    National Library of Medicine. Medical Subject Headings Browser. Available at URL: http://www.nlm.nih.gov/mesh/2006/MBrowser.html Accessed on October 31, 2006.
  • 114
    Pocock SJ, Collier TJ, Dandreo KJ, et al. Issues in the reporting of epidemiological studies: a survey of recent practice. BMJ. 2004; 329: 883.
  • 115
    Air Resources Board, Proposed Identification of Environmental Tobacco Smoke as a Toxic Air Contaminant. Sacramento, CA: California Environmental Protection Agency; 2005.
  • 116
    Michels KB, Mohllajee AP, Roset-Bahmanyar E, Beehler GP, Moysich KB. Diet and breast cancer: a review of the prospective observational studies. Cancer. 2007; 109: 000–000.
  • 117
    The Sister Study: A Study of the Environmental and Genetic Risk Factors for Breast Cancer. Available at http://www.sisterstudy.org/English/index1.htm Accessed on July 10.
  • 118
    National Center for Health Statistics. National Health and Nutrition Examination Survey: NHANES 2003–2004 Data Files. Available at http://www.cdc.gov/nchs/about/major/nhanes/nhanes2003–2004/nhanes03_04.htm Accessed on October 31, 2006.
  • 119
    U.S. Environmental Protection Agency, Indoor Air—Assessment: Methods of Analysis for Environmental Carcinogens. Washington, DC: U.S. Environmental Protection Agency; 1990.
  • 120
    Clarke CA, Purdie DM, Glaser SL. Population attributable risk of breast cancer in white women associated with immediately modifiable risk factors. BMC Cancer. 2006; 6: 170.
  • 121
    Rockhill B, Weinberg CR, Newman B. Population attributable fraction estimation for established breast cancer risk factors: considering the issues of high prevalence and unmodifiability. Am J Epidemiol. 1998; 147: 826–833.
View Full Article (HTML) Get PDF (342K)